Deep brain stimulation (DBS) is currently being investigated in patients and preclinical models of posttraumatic stress disorder (PTSD), but differences in behaviour according to sex remain elusive. We exposed female and male rats to fear conditioning and extinction. Thereafter, animals were treated with ventromedial prefrontal cortex DBS, followed by a battery of tests to measure fear and anxiety-like behaviour. As in our prior work, animals with high freezing scores during extinction (weak extinction; WE) were segregated from those with lower freezing scores (non-weak extinction; nWE), since the former population was previously shown to develop prolonged fear and anxiety-like responses. Vaginal lavages were collected after fear extinction to study the estrous cycle. After the experiments, brains were processed for the measurement of estrogen (ER) and progesterone receptors (PR) in the hypothalamus and hippocampus. We found that DBS-treated males had a more pronounced reduction in freezing than females during all recall sessions. In females, DBS induced an anxiolytic-like effect in the open field, while a reduction in the latency to feed during novelty suppressed feeding was noticed in both sexes. Noteworthy, a reduction in freezing during recall and anxiolytic-like responses following DBS were observed in males of all phenotypes, but only in nWE females. While no effect of the estrous cycle was noticed on fear memory, DBS-treated females in metestrus/diestrus during extinction had a more prominent response in the elevated plus maze. A similar expression of ERα, ERβ and PRβ in the hypothalamus and hippocampus was found in DBS-treated females and controls.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jpsychires.2025.02.041 | DOI Listing |
Pharmacol Rep
March 2025
Department of Pharmacology and Brain Biostructure, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland.
Background: Serotonin is strongly involved in the regulation of brain development, including the proper formation of neuronal circuits and synaptic plasticity. One of the factors that can affect brain serotonin levels is exposure to fluoxetine (FLX), a selective serotonin reuptake inhibitor, the first-line pharmacological treatment for depression and anxiety in the pediatric population. The safety of early-life FLX treatment is still questionable.
View Article and Find Full Text PDFProg Neuropsychopharmacol Biol Psychiatry
March 2025
School of Medicine, Western Sydney University, NSW 2560, Australia. Electronic address:
Increasingly, the cannabis sativa plant compound cannabidiol (CBD) is used to treat various psychiatric and neurological health conditions which occur in early life or adolescence, including schizophrenia and autism spectrum disorder. However, behavioural effects CBD during adolescence have received limited attention, and the long-lasting behavioural consequences of adolescent CBD treatment are unknown. Thus, this study investigated the effects of chronic CBD in adolescence on behaviours in adulthood, in a mouse model of susceptibility to cannabinoid drugs and schizophrenia, i.
View Article and Find Full Text PDFJ Psychiatr Res
February 2025
. Sunnybrook Research Institute, Toronto, ON, M4N 3M5, Canada; . Harquail Centre for Neuromodulation, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, M4N 3M5, Canada; . Division of Neurosurgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, M4N 3M5, Canada. Electronic address:
Deep brain stimulation (DBS) is currently being investigated in patients and preclinical models of posttraumatic stress disorder (PTSD), but differences in behaviour according to sex remain elusive. We exposed female and male rats to fear conditioning and extinction. Thereafter, animals were treated with ventromedial prefrontal cortex DBS, followed by a battery of tests to measure fear and anxiety-like behaviour.
View Article and Find Full Text PDFNeuropsychiatr Dis Treat
February 2025
Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA.
Purpose: Brexpiprazole, when administered with antidepressant therapy, may provide additional benefits due to complementary actions on noradrenaline (norepinephrine), serotonin, and dopamine neurotransmitter systems. This review addressed the question: what information can preclinical studies provide on the use of brexpiprazole + antidepressant treatment?
Methods: A systematic literature review was conducted to search for preclinical studies of brexpiprazole + antidepressant therapy that included a behavioral test relating to any psychiatric disorder. Ovid MEDLINE, Ovid Embase, and conference abstracts were searched (January 1, 2011-July 5, 2021).
Behav Brain Funct
March 2025
Sagol Department of Neurobiology, University of Haifa, 3498838, Haifa, Israel.
Background: Neuronal plasticity within the basolateral amygdala (BLA) is fundamental for fear learning. Metaplasticity, the regulation of plasticity states, has emerged as a key mechanism mediating the subsequent impact of emotional and stressful experiences. After mRNA knockdown of synaptic plasticity-related TrkB, we examined the impact of chronically altered activity in the rat BLA (induced metaplasticity) on anxiety-like behavior, fear memory-related behaviors, and neural plasticity in brain regions modulated by the BLA.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!